Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)
Condition: Rhinitis, Allergic Interventions: Drug: Mometasone furoate nasal spray (MFNS); Drug: Loratadine; Drug: Placebo nasal spray; Drug: Placebo tablet Sponsor: Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials
Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)
Condition: Seasonal Allergic Rhinitis Interventions: Drug: Mometasone Furoate (MF); Drug: Beclomethasone Dipropionate (BDP); Drug: Placebo Sponsor: Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials
Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis
Conditions: Chronic Rhinosinusitis (Diagnosis); Allergic Rhinosinusitis; Chronic Eosinophilic Rhinosinusitis Interventions: Drug: Mometasone Furoate Nasal Irrigation; Drug: Mometasone Nasal Spray Sponsor: Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 15, 2018 Category: Research Source Type: clinical trials
Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)
Condition: Seasonal Allergic Rhinitis Interventions: Drug: Molo 1 (also referred as GSP 301-2 NS); Drug: Molo 2 (also referred as GSP 301-1 NS); Drug: Placebo nasal spray; Drug: DYMISTA nasal spray; Drug: PATANASE nasal spray Sponsor: Glenmark Pharmaceuticals Ltd. India Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2018 Category: Research Source Type: clinical trials
